Delivery Order SPE2DB22D1056-SPE2DB25FSHP8
Award Date 8/19/25
Potential Completion Date 8/20/25
Potential Value $1.1K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency (DLA) awarded AmerisourceBergen Drug Corp a delivery order valued at $26,197.80 on July 22, 2025, for the supply of Cyclophosphamide 2 GM vials, with an ultimate completion date of July 23, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at AmerisourceBergen's Conshohocken, Pennsylvania facility. The award represents a child contract under AmerisourceBergen's larger Indefinite Delivery...
- The Defense Logistics Agency Troop Support Medical awarded a $163,850 firm fixed price delivery order contract to Amerisourcebergen Drug Corporation for 100 capsules of the pharmaceutical cyclophosphamide. The place of performance will be Amerisourcebergen's facility located in Conshohocken, Pennsylvania. The contract period of performance spans from August 16, 2023 through August 17, 2023. No major subcontractors or set aside designations were indicated. This delivery order was issued against...
- The Defense Logistics Agency Troop Support Medical awarded a $4,438 firm fixed price delivery order to Amerisourcebergen Drug Corporation for cyclophosphamide. The order was placed under an existing Prime Vendor contract vehicle to supply pharmaceutical products and services to DLA and the Department of Defense. Amerisourcebergen will deliver the cyclophosphamide to its facility in Conshohocken, Pennsylvania by September 27, 2023 to support DLA's medical supply chain initiatives. No...
- This delivery order, awarded on August 12, 2025, by the Defense Logistics Agency to AmerisourceBergen Drug Corp, provides for the supply of Cyclophosphamide 2 GM vials with a ceiling value of $7,341.10 under firm fixed pricing. The award is a non-set-aside contract and represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. Performance will be conducted...
- The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of 4563447861 CYCLOPHOSPHAMIDE 2 GM VIALS. The potential value of this contract is $7,551.05 and the performance period runs through January 26, 2024. Amerisourcebergen Drug Corp is the prime contractor and holds an indefinite delivery contract (IDC) with DLA, valued up to $999,999,999.00 through December 31, 2025, which serves...
- The U.S. Department of Defense's Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide 4,564,118,918 units of the pharmaceutical product Cyclophosphamide 1 GM/5 ML VL 5ML. The order, valued at $1,449.08, has an ultimate completion date of April 1, 2024. Amerisourcebergen Drug Corp holds an indefinite delivery contract with DLA Troop Support Medical, valued...
- The Defense Logistics Agency awarded a $9,244.71 firm fixed price delivery order to Amerisourcebergen Drug Corp for 2 grams vials of the chemotherapy drug cyclophosphamide. As the prime contractor, Amerisourcebergen Drug Corp will deliver the vials to a location in Conshohocken, Pennsylvania by September 6, 2023 under the terms of this order issued against an existing DLA contract vehicle. Amerisourcebergen Drug Corp is a division of Amerisourcebergen Corporation, a major pharmaceutical...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Cyclophosphamide 2 gm/10 ml vials. The contract has a ceiling value of $3,053.00 and a completion date of June 23, 2025. It is a firm-fixed-price contract and is not set aside for any specific business type. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
- The Defense Logistics Agency awarded a $2,371.74 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 4562143232 CYCLOPHOSPHAMIDE 1 GM/5 ML VL 5ML. The place of performance is Conshohocken, Pennsylvania. The order period is September 12-13, 2023. Amerisourcebergen Drug Corporation, a division of Amerisourcebergen Corporation, will fulfill the order for this chemotherapy medication to support the Defense Logistics Agency's medical supply chain programs. No subcontractors or...
- This federal contract award is for the delivery of Cyclophosphamide 2 GM vials to the Defense Logistics Agency (DLA). The $9,120.41 fixed-price contract was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, on December 6, 2024, with a performance period ending on December 9, 2024. The contract is a delivery order under an Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop Support Medical, which serves as a primary...